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We have previously shown that the phosphoprotein (P) of vesicular stomatitis virus (VSV), New Jersey serotype (PNJ) is
phosphorylated by casein kinase II, within the N-terminal domain I (P1 form), whereas the C-terminal domain II is phosphory-
lated by a protein kinase activity associated with the L protein (P2 form) (D. J. Chattopadhyay and A. K. Banerjee, Cell 49,
407, 1987; A. M. Takacs et al., J. Virol. 66, 5842, 1992). In the present studies, we have mapped the corresponding P1 and
P2 phosphorylation sites in the P protein of the well-studied Indiana serotype (PIND) and compared that with the two previously
designated NS1 and NS2 forms present in vivo. The PIND expressed in Escherichia coli in an unphosphorylated form (P0)
was used as substrate for recombinant casein kinase II (CKII). By site-directed mutagenesis, the CKII-mediated phosphoryla-
tion sites in the P protein were mapped at S60, T62, and S64 within the acidic domain I in vitro. In contrast, using BHK cell
extract as the source of CKII or expressing P protein in COS cells labeled with 32Pi, the phosphorylation sites were mapped
at S60 and S64 with no phosphorylation at T62 residue. We used a peptide mapping technique by which the phosphorylation
sites within domain I and domain II were determined. Using this method we demonstrated that the P1 and P2 forms are
similar, if not identical, to the previously designated NS1 and NS2 forms, respectively. The domain II phosphorylating kinase
activity, associated with the L protein, is shown to be present also in the N-RNA complex, indicating that this activity is of
cellular origin. By site-directed mutagenesis, we have shown that S226 and S227 are involved in phosphorylation within
domain II. We also demonstrate that the P1 and P2 forms are interconvertible and arise by phosphorylation/dephosphoryla-
tion of the phosphate groups in domain II, confirming the precursor–product relationship between the two phosphorylated
forms of P protein. q 1997 Academic Press
INTRODUCTION Banerjee, 1988; Peluso, 1988). The soluble N–P complex
interacts with the nascent RNA transcripts, encapsidates
The phosphoprotein (P) (previously designated as NS the elongating RNA, and facilitates synthesis of plus-
protein) of vesicular stomatitis virus (VSV) is an indis- strand genome RNA encapsidated with the N protein.
pensable auxiliary component that imparts biological ac- The plus-sense RNP, in turn, serves as template for the
tivity to the RNA polymerase (L) (Emerson and Wagner,
synthesis of progeny negative-sense genome RNP. Thus,
1973; Emerson and Yu, 1975; Banerjee, 1987; Banerjee
the multifunctional property of the P has provided a
and Barik, 1992). The purified virions contain the P pro-
strong impetus to study the structure and function of this
tein complexed with the L protein, which transcribes the
vital protein.nucleocapsid protein (N)-enwrapped genome RNA in
The various phosphorylated states of the NS (P) pro-vitro to synthesize functional mRNAs. Similar transcrip-
tein and their relation to NS (P) function have long beentionally active complex is found de novo during infection,
known and were the major focus of study for a numberwhich participates in the secondary transcription pro-
of years in VSV research (Clinton et al., 1979; Kingsfordcess. Although the primary function of P protein has long
and Emerson, 1980; Hsu et al., 1982; Sinacore and Lucas-been recognized as the necessary subunit of the RNA
Lenard, 1982; Masters and Banerjee, 1986). Using thepolymerase complex, recent results clearly demonstrate
well-studied Indiana serotype of VSV, the NS protein hasthat P protein has a major role in the replication of ge-
been shown to exist in at least two phosphorylated forms,nome RNA (Peluso and Moyer, 1988; Howard and Wertz,
designated NS1 and NS2, clearly separable by urea –1989; LeFerla and Peluso, 1989; Das and Banerjee, 1992).
SDS–polyacrylamide gel electrophoresis (PAGE), theThe P protein associates with newly synthesized N pro-
NS2 being more phosphorylated than NS1, and appearedtein during infection to keep the latter in a soluble, repli-
to be formed by additional phosphorylation of the NS1cation competent form (Davis et al., 1986; Masters and
form (Clinton et al., 1979; Hsu and Kingsbury, 1982). It
was difficult to purify these two phosphorylated forms
The findings described in this communication were presented in part either from the virion or from infected cells. Thus, their
at the Annual Meeting of the American Society for Virology held at the precise roles in transcription or replication processesUniversity of Austin, Texas, 1995.
remained unclear. However, in several studies, attempts1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (216) 444-0512. were made to separate and purify NS1 and NS2 forms
2000042-6822/97 $25.00
Copyright q 1997 by Academic Press
All rights of reproduction in any form reserved.
AID VY 8401 / 6a28$$$741 02-04-97 20:18:29 vira AP: Virology
201PHOSPHORYLATED STATES OF VSV P PROTEIN
(Kingsford and Emerson, 1980), and the results from such protein to carry out detailed analyses of the phosphory-
lated states of the P protein in vitro and in vivo. In thisstudies strongly suggested that the transcription of ge-
nome RNA was dependent on the phosphorylated state communication, using E. coli expressed P0 protein and
extensive mutational analysis, we have identified theof the NS protein; the hyperphosphorylated NS2 form
appeared to be more active than the less phosphorylated phosphorylation sites in P1 and P2 of PIND . We have
also carried out peptide map analyses of P1 and P2 andNS1 form. It was not known which form of the phosphory-
lated NS protein complexed with the N protein in the compared them with the corresponding peptides ob-
tained from the so-called NS1 and NS2 forms. Our resultsinfected cells. Recently, the NS2 form (Chang et al.,
1994b) and a third subset of P protein in the infected cells demonstrate that P1 and P2 phosphorylated forms are
similar, if not identical, to the NS1 and NS2 forms, respec-(Richardson and Peluso, 1996) have been implicated in
regulating replication of the genome RNA. The degree tively, and the two forms are interconvertible. Moreover,
we have established that the LAK is a cellular kinase,of phosphorylation as well as the precise sites of phos-
phorylation of these NS species remained undetermined. which remains tightly bound to the L protein as well as
the N-RNA complex and is responsible for phosphoryla-However, by two-dimensional gel electrophoresis, a sig-
nificant number of subsets of phosphorylated forms of tion of P protein within domain II at precise serine resi-
dues.NS protein were found in the infected cells (Hsu et al.,
1982), suggesting that phosphorylation may occur at mul- (The findings described in this communication were
presented in part at the Annual Meeting of the Americantiple sites on the protein. From biochemical analyses,
the major phosphorylation sites were found to be local- Society for Virology held at the University of Austin,
Texas, 1995.)ized near the N-terminal half of the protein (Marnell and
Summers, 1984; Bell and Prevec, 1985; Hsu and
Kingsbury, 1985).
MATERIALS AND METHODSA significant advance in the study of P (NS) protein
phosphorylation was achieved by expressing P protein
Cell cultures and virus(New Jersey serotype) (PNJ) in Escherichia coli in an un-
phosphorylated form and studying its biological function
Baby hamster kidney (BHK-21) and COS-1 cells were(Barik and Banerjee, 1991) using a transcription-reconsti-
grown in DMEM (Gibco-BRL) containing 7% heat inacti-tution system in vitro containing virion purified L protein
vated fetal bovine serum (FBS; Gibco-BRL). VSV(IND)and N-RNA template. It was shown that the unphosphory-
Mudd-summers strain was propagated and purified aslated form of P (P0) is biologically inactive unless phos-
described previously (Banerjee et al., 1974; Barik andphorylated by a cellular kinase, which was later identified
Banerjee, 1991) from BHK-21, by innoculating with virusas the ubiquitous cellular casein kinase, CKII (Barik and
at a multiplicity of infection of 0.05.Banerjee, 1992b). The CKII-mediated phosphorylation
rendered P0 to a form designated P1. A second phos-
phorylation event also took place, which is mediated by Construction of P mutant plasmids
a protein kinase activity associated with the purified L
protein (designated LAK) which converted P1 to a P2 The site-directed mutageneses within domain I and II
of the P gene were carried out by the revised megaprimerform (Barik and Banerjee, 1992a). The P0, P1, and P2
forms were clearly separable by DEAE-cellulose chroma- PCR method, as described previously (Takacs et al.,
1992). The plasmid pET-3a-PHis containing P gene of Indi-tography. The CKII-mediated phosphorylation occurred
on S59 and S61 within the N-terminal acidic domain (Ta- ana serotype with histidine tag at the C-terminal end
was used as a template in all PCR amplification. For thekacs et al., 1992), whereas the LAK-mediated phosphory-
lation occurred on S236 and S242 (domain II), the phos- construction of each P mutant plasmid, a two-step PCR
was performed. In the first step, two oligonucleotidesphorylation of which was implicated in P protein tran-
scriptive function (Chattopadhyay and Banerjee, 1987). where one contains the designated mutation were used
to create a megaprimer product, which was then usedThe CKII-mediated phosphorylation activates the P pro-
tein and facilitates oligomerization of the P1 protein with along with the third oligonucleotide in the second step
PCR, to obtain the full-length mutant P gene. The PCRsubstantial increase in its a-helical structure, which may
be involved in imparting its biological function (Das et amplified products were restricted with NdeI and BamHI
and ligated into pET-3a vector DNA at the NdeI andal., 1995a). Since the major studies in VSV research have
been carried out with the P protein of Indiana serotype BamHI sites. All mutations were confirmed by dideoxy
sequencing of the gene.(PIND), the precise relationship of P1 and P2 forms of PNJ
with the previously designated NS1 and NS2 forms of For transfection experiments, the wild-type and all the
mutant P genes were subcloned into mammalian expres-PIND was not immediately evident. Recently, we (Chen et
al., 1995) and others (Gao and Lenard, 1995a, 1995b; sion vector pECE at SalI and SacI sites. To generate new
restriction sites at the 5* and 3* ends of the P gene, twoJackson et al., 1995) have directed attention to the PIND
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hanced chemiluminescence reagent (Amersham) and
exposed to X-ray film. The autoradiograph was scanned
with a scanning densitometer (Bio-Rad model 620) to
determine the amount of P protein in each lysate. Based
on these data, the volume of each cell extract was ad-
justed so that an equal amount of P protein would be
present in each lane. The amount of 32P present in P
protein in each lane was quantitated using a phosphoi-
mager (Molecular Dynamics). The 32P/protein ratio was
calculated for each P mutant and wild-type protein. The
32P incorporation in mutant P proteins was expressed as
a percentage of the wild-type 32P/protein ratio.
For radiophosphate labeling of virus, BHK monolayers
in 100-mm petri dish were infected with VSV (Indiana
serotype, Mudd-summers strain) at an m.o.i. of 0.05. At
4 hr postinfection, the medium was replaced by phos-
phate-free MEM without FBS. Cells were starved for 1
hr at the end of which the medium was again replaced
FIG. 1. Schematic representation of VSV(IND) P protein. The entire by 5 ml phosphate-free MEM containing 3% FBS and 500
P protein containing all domains is shown. The solid dots in domains
mCi of 32Pi (9000 Ci/mmol; Du Pont). Cells were incubatedI and II indicate the possible phosphorylation sites. An enlargement of
for another 15–16 hr and the 32P-labeled virus was har-domain I shows the location of five serine and threonine residues
conserved between the Indiana and New Jersey serotypes. The differ- vested and pelleted as described earlier (Barik and Ban-
ent mutant P proteins where serine or threonine was altered to alanine erjee, 1991).
are shown.
Purification of viral components
The isolation of ribonucleoprotein (RNP) and purifica-primers (the upstream primer contains SalI site, whereas
tion of N-RNA template and L protein was carried outthe downstream primer contains SacI site) were used to
essentially as described (Das et al., 1995a). For theamplify the P gene by PCR method from pET-3a-P plas-
source of N-RNA associated kinase (NAK), N-RNA wasmid. The PCR-amplified products were then digested
prepared by repeated high salt washes of RNP obtainedwith SalI and SacI and ligated into pECE vector DNA at
from 20 mg of purified virus and centrifugation throughthe SalI and SacI sites. The positive clone was identified
15% Renografin as described previously (Das et al.,by restriction analyses and further confirmed by se-
1995a) and was finally purified by equilibrium bandingquencing.
in 0.35 g/ml CsCl in 10 mM Tris–HCl, pH 8.0, 1 mM EDTA
(TE) in a Beckman SW40 rotor at 35,000 rpm for 24 hrRadiolabeling, immunoprecipitation, and Western blot
at 207. N-RNA was dialyzed against TE containing 10%analysis
glycerol. If necessary, N-RNA was further purified repeat-
edly through CsCl gradient to remove associated cellularCOS-1 cells in 60-mm dish (70–80% confluent) were
transfected with 3 mg of pECE-P plasmid DNA, by using kinase. Any contaminating kinase activity in N-RNA was
eventually destroyed by controled heat tratment, as de-lipofectamine according to the manufacturer’s (Life Tech-
nologies) protocol. At 36 hr posttransfection, cells were scribed previously (Barik and Banerjee, 1992a). All puri-
fied viral components were stored at 0807C.starved in phosphate-free MEM for 2 hr. The cells were
labeled with 125 mCi of 32Pi (9000 Ci/mmole; Du Pont) in
Purification of recombinant P proteins from E.coli1.25 ml of the same phosphate-free medium containing
BL21(DE3)1% FBS for 4 hr. The cells were washed twice with PBS
and lysed in 0.5 ml RIPA buffer (50 mM Tris–HCl, pH 7.5, Recombinant P proteins were expressed and purified
essentially as described previously (Barik and Banerjee,150 mM NaCl, 0.5% Triton X-100, 0.5% deoxycholate, 0.1%
SDS, 1 mM PMSF) for 5 min on ice. The whole cell lysates 1991; Das et al., 1995b). However, the elution of the P
protein from nickel affinity column was ommitted as thewere immunoprecipitated with anti-P antibody as de-
scribed before (Das et al., 1995b). The immunoprecipi- P protein was approximately 80–90% homogeneous after
recovering from inclusion bodies by guanidine hydro-tates were electrophoresed on a 10% SDS–polyacryl-
amide gel. Western blot was performed essentially as chloride and was as active as affinity purified P protein.
described (Das et al., 1995b). The membrane was first
In vitro phosphorylationprobed with anti- P antibody followed by secondary anti-
body according to the membrane manufacturer’s (Bio- In a standard protein kinase assay, 2–3 mg of P protein
was incubated in the presence of recombinanat CKIIRad) protocol. Finally, the blot was developed with en-
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FIG. 2. Phosphorylation analyses of domain I mutant P proteins. In vitro phosphorylation of bacterially expressed mutant P proteins was carried
out in the presence of either (A) recombinant CKII or (B) BHK cell extract, as detailed under Materials and Methods. (C) In vivo labeling of mutant
P proteins in COS-1 cells was performed as described under Materials and Methods. 32P/protein ratios in the mutants from each experiment were
expressed as a percentage of the wild-type 32P/protein ratio from the same experiment, and the percentage phosphorylation of each mutant was
then calculated. The percentage phosphorylation of the wild-type P protein was taken to be 100%. 32P incorporation was measured by phosphoimager
while the amount of protein was detected either by coomassie staining (in case of A and B) or by immunoblot (in case of C) and quantitated by
scanning densitometer.
(0.01 mU), or 1 mg of cell extract, or 1 mg of N-RNA urea; all other components were those of the standard
discontinuous system of Laemmli (1970). 32P-labeled pro-template, as the source of protein kinases in 20 ml reac-
tion mixture containing 50 mM Tris–HCl, pH 8.0, 5 mM teins were visualized by autoradiography; where quanti-
tation is given, radiation was counted with the help ofMgCl2 , 1 mM DTT, 100 mM NaCl, 100 mM ATP, and 10
mCi of [g-32P]ATP (Dupont, 3000 Ci/mmol). Reactions phosphoimager.
were carried out at 307 for 2 hr and immediately stopped
by adding Laemmli buffer followed by electrophoresis Peptide mapping
on a 10% SDS–polyacrylamide gel (Laemmli, 1970). To
analyze the NS1 and NS2 forms of the P protein, the Both in vitro and in vivo phosphorylated P proteins
were electrophoresed on a 10% urea–SDS–polyacryl-kinase reactions were electrophoresed on a urea–SDS –
gel in which resolving gel contained 10% polyacrylamide amide gel, and the different phosphorylated forms of the
P protein were visualized by autoradiography for a short(0.26% bisacrylamide), 187.5 mM Tris–HCl, pH 8.8, 5 M
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CKII consensus motif, whereas T49 and S52 are highly
conserved within several VSV serotypes (Gill and Ban-
erjee, 1985; Masters and Banerjee, 1987). To map pre-
cisely the residues involved in CKII-mediated phosphory-
lation in vitro, each S and T residue was altered to A
individually as well as in various combinations as de-
tailed in Fig. 1. Individual mutant P protein was expressed
in E. coli, purified and used as substrate for phosphoryla-
tion in vitro using recombinant CKII. As shown in Fig. 2A,
when S60, T62, and S64 were altered to A (P3A), no
incorporation of 32P occurred, indicating that T49 and S52
are not phosphorylated by recombinant CKII, whereas
the other three residues are involved in CKII-mediated
phosphorylation. Alteration of a single residue (P60, P62,
P64) or two residues (P60/62, P62/64, P60/64) resulted in
approximately 35 and 70% decrease in phosphorylation,
respectively. The percentage phosphorylation in mutant
FIG. 3. Resolution of phosphorylated P protein in urea-SDS gel. The P proteins was calculated based on the amount of P
phosphorylated P1 protein (32P labeled) was obtained either by in vitro protein used in each experiment by Coomassie blue
phosphorylation of P0 with recombinant CKII or by in vivo labeling of
staining followed by densitometric scanning. Interest-P protein in COS cells as detailed under Materials and Methods. In
ingly, when BHK cell extract was used as the source ofthe case of viral L/P or viral RNP, 1 mg of purified L/P fraction or 2
mg of RNP was incubated for 2 hr in phosphorylation reaction with [g- CKII (Fig. 2B), the T62 residue seemed not to be important
32P]ATP. The phosphorylated P protein as well as purified 32P labeled for phosphorylation, since altering T to A (P62) did not
virion (1–2 mg) were electrophoresed in a 10% polyacrylamide gel decrease phosphorylation appreciably. In contrast, alter-
containing SDS and 5 M urea as described under Materials and Meth-
ation of either S60 (P60) or S64 (P64) decreased phos-ods. The different phosphorylated forms of the P protein are indicated
phorylation by approximately 50% and there was virtuallyas P1, NS1, and NS2.
no phosphorylation when both S60 and S64 (P60/64)
were altered. These results strongly suggest that the
period. The 32P-labeled bands were excised and placed affinity of CKII for T62 is significantly lower than S60
in the slots of a protein electro-eluter (Bio-Rad, model
422). The labeled proteins were eluted and subjected to
protease digestion after concentrating into small volume
by amicon concentrator. For enzymatic proteolysis of the
labeled P protein, conditions that ensured complete di-
gestion were first established by using different protein/
enzyme ratios. Endolys-C digestion was carried out in a
buffer containing 25 mM Tris–HCl, pH 8.5, 1 mM EDTA
for 18 hr at 377 while Chymotrypsin digestion was per-
formed in a buffer containing 100 mM Tris–HCl, pH 7.8,
10 mM CaCl2 for 18 hr at 257. Endolys-C and chymotryp-
sin were purchased from Boehringer Mannheim, Inc. The
cleaved products were analyzed either in 20% SDS–poly-
acrylamide gel (Laemmli, 1970) or in 40% alkaline–poly-
acrylamide gel (Dadd et al., 1993), depending upon the
size of the peptide.
RESULTS
CKII-mediated phosphorylation sites in P protein FIG. 4. Predicted protease map of PIND . The peptidase map of the
P protein was derived from amino acid sequence using Gene Works
Using bacterially expressed P protein, we have pre- version 2.3.1. A complete digestion of the P protein by Endolys-C re-
leases two peptide fragments which cover the predicted phosphoryla-viously shown that S59 and S61 are the two sites within
tion sites within the P protein. A 75-mer peptide spanning 35 to 110the acidic domain of PNJ phosphorylated by CKII in vitro
amino acids contains the domain I phosphorylation sites while the 32-and in vivo (Takacs et al., 1992). Within the corresponding
mer peptide spanning 212 to 244 contains the domain II phosphoryla-
region of PIND , there are five serine and threonine resi- tion sites. Further digestion of the 75-mer peptide with chymotrypsin
dues that are potential phosphorylation sites (Fig. 1). The releases a 21 amino acid long peptide spanning 55 to 76 amino acid
which maps the CK II sites, i.e., S60, T62, and S64.S60, T62, and S64 residues are located within a typical
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FIG. 5. Peptide mapping of P1 and NS1. P1 protein was obtained either by in vitro phosphorylation of P0 with recombinant CKII or by in vivo
labeling in COS cells. NS1 was obtained either in vitro from viral L/P fraction or from in vivo 32P-labeled virions. The 32P-labeled P1 and NS1 were
purified from urea-SDS polyacrylamide gel and subsequently subjected to Endolys-C-digestion (A). The cleaved products were analyzed in 20%
polyacrylamide gel followed by autoradiography. The migration positions of BRL low molecular weight markers (kDa) are shown. The 75-mer
phosphopeptide migrates around 10 kDa. The 75 amino acid long phosphopeptide derived from P1 and NS1 was further digested with chymotrypsin
(B) as detailed under Materials and Methods. The cleaved products were analyzed in 40% alkaline polyacrylamide gel followed by autoradiography.
The migration positions of bromophenol blue (20 a.a.) and CKII peptide (10 a.a.) (Barik and Banerjee, 1992b) are shown.
and S64 in vivo. The observed phosphorylation of P60/ and NS2. These two forms are easily identified when
64 mutant in vitro in Fig. 2A is possibly due to high spe- phosphorylated NS is subjected to SDS–PAGE in the
cific activity of recombinant CKII used in phosphorylation, presence of urea (Clinton et al., 1979). As shown in Fig.
while in the cell extract, the CKII activity is presumably 3, 32P-labeled virion produced the chraracteristic NS1
low. Alternatively, the phosphorylated T62 may be selec- and NS2 forms. Similarly, when the viral RNP or the L/P
tively dephosphorylated by the phosphatase(s) present isolated from virion were incubated in the presence of
in the cell extract. In fact, the latter contention seems to [g-32P]ATP, virion-associated kinase(s) produced NS1
be correct because exogeneous addition of recombinant and NS2 forms which were clearly discernible. Taken
CKII to BHK cell extract did not phosphorylate T62 (data together, these results demonstrate that both forms of
not shown). Thus, it seems that cellular phosphatases NS proteins are produced in vivo and in vitro. In the same
removes efficiently the phosphate group from T62. It is gel electrophoretic system, both in vitro phosphorylated
important to note that by phosphoamino acid analyses, P1 [P1(CKII)] or in vivo-labeled P protein expressed in
all single (P60, P62, P64) and double (P60/62, P62/64) COS cells [P1(COS)] migrated with NS1 species only.
mutants (Fig 2B) released phosphoserine residue only Similar results were also obtained when BHK extract was
(data not shown), indicating that T62 is not phosphory- used as the source of CKII to phosphorylate P0 (data not
lated by the cell extract. shown). Since we have already established (Fig. 2) that
When these P mutants were expressed in COS cells the P1 form is produced exclusively by phosphorylation
and metabolically labeled with 32Pi, the degree of phos- within domain I by CKII, it is reasonable to conclude
phorylation of the mutants was very similar to that seen based, at least, on the electrophoretic mobility, that NS1
in vitro with BHK cell extract as the source of cellular form is possibly identical to the P1 form where S60 and
kinase (compare Figs. 2B and 2C). Thus, the above series S64 residues are phosphorylated.
of experiments indicate that S60 and S64 residues are To further confirm this contention, we carried out a
directly involved in CKII-mediated phosphorylation within peptide mapping analysis to locate precisely the phos-
the cell. The T62 is either not phosphorylated in vivo or phorylated domain within the P protein and compared
the phosphate group is sensitive to phosphatase(s). that with the so-called NS forms. As shown schematically
in Fig. 4, complete digestion of P protein with endolysine
Relationship between P1 and NS1
C is predicted to release two peptides spanning amino
acids 35 to 110 (75 a.a.) and amino acids 212 to 244 (32It has been known for some time that the PIND exists
at least in two phosphorylated forms, designated NS1 a.a.) in addition to a series of smaller fragments. The
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FIG. 6. Phosphorylation of P protein by N-RNA associated kinase (NAK). (A) 3 mg of bacterially expressed P protein was incubated with 1
mg of N-RNA template in an in vitro phosphorylation reaction for 2 hr in the presence of [g-32P]ATP. To compare the electrophoretic mobility
of the phosphorylated forms (obtained by NAK) with that of NS1 and NS2, 1 mg of virion purified L/P complex was incubated with [g-32P]ATP.
The phosphorylated P proteins were analyzed in 10% urea-SDS polyacryalmide gel. The phosphorylated forms of the P protein obtained by
NAK is designated as P1 and P2. (B) Endolys-C digestion of P2 and NS2. NS2 was obtained either in vitro from viral L/P or from 32P-labeled
virions. The digested products were analyzed on 20% SDS – polyacrylamide gel. The Endolys-C fragment of P1 was run as a control. The
migration positions of BRL low molecular weight markers (kDa) are shown. The 32-mer phosphopeptide migrated around 4 kDa.
former peptide covers the CKII-mediated phosphoryla- Relationship between P2 and NS2
tion sites in domain I, whereas the latter peptide covers
The protein kinase which phosphorylates domain II ofthe putative domain II phosphorylation sites. The 75 a.a.
the P protein was originally found to be strongly associ-long peptide, upon further digestion with chymotrypsin,
ated with the L protein of VSV Indiana serotype (Sanchezwould release a peptide of 21 a.a. long spanning amino
et al., 1985). Similar activity was subsequently found to beacids 55–76 containing the precise CKII-mediated phos-
associated with the L protein of New Jersey (Hammond etphorylation sites (S60 and S64). Thus, this mapping pro-
al., 1992), which was shown to phosphorylate S236 andcedure would enable us to locate the phosphorylation
S242 residues within domain II and that presumably con-sites in both NS1 and NS2 forms as well as the P1 and
verted P1 to P2 form (Barik and Banerjee, 1992a) andP2 forms. The results of such peptide mapping experi-
regulated the biological function of the P protein (Chatto-ments are shown in Fig. 5. The CKII-phosphorylated P
padhyay and Banerjee, 1987). However, the L associatedprotein [P1(CKII)] as well as P1 obtained from COS cells
kinase, later termed LAK (Gao and Lenard, 1995a), was[P1(COS)], when digested with lysC, as expected, re-
recently shown to be of cellular origin, because the Lleased a phosphopeptide in 20% SDS–PAGE which mi-
protein could be effectively purified devoid of associatedgrated as 75 a.a. peptide as judged by the migration
kinase activity (Massey et al., 1990).position of the molecular weight marker (10 kDa) (Fig.
To investigate whether the NS2 species is identical to5A). Similarly, lysC digestion of phosphorylated NS1 ob-
the P2 and both species are indeed produced followingtained either in vitro from viral L/P or from in vivo 32P-
phosphorylation within domain II by LAK, we first purifiedlabeled virion (Fig. 3) released the same 75 a.a. long
L free from associated P protein but containing LAK activ-phosphopeptide. Further digestion of these 75-mer phos-
ity from purified virion (Barik and Banerjee, 1992a). Whenphopeptides with chymotrypsin produced a phosphopep-
P0 was used as substrate, the LAK activity phosphory-tide migrating with the bromophenol blue marker (20 a.a.)
lated the P protein and produced both P1 and P2 species(Fig. 5B), indicating that the NS1 form is phosphorylated
which comigrated with NS1 and NS2, respectively (datasolely within 55–76 a.a. (21 a.a.). Thus, it seems that the
not shown). Since P1 is produced primarily by phosphory-CKII-mediated phosphorylation of the P protein occurs
both in vitro and in vivo within domain I, presumably at lation mediated by CKII, these results indicated that the
LAK preparation contained CKII (Gupta et al., 1995). TheS60 and S64, and the P1 species are indeed similar, if
not identical, to the so-called NS1 species. LAK preparation obtained by this procedure routinely
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contained low enzymatic activity. Moreover, purification
of the enzyme from the virion entailed usage of a signifi-
cant amount of virus. Accordingly, we sought an alternate
source of LAK. We have previously observed that a pro-
tein kinase activity was also routinely associated with
the purified N-RNA complex of Indiana serotype, which
phosphorylated the PIND protein effectively and produced
the NS2 form (Masters and Banerjee, 1986). The protein
kinase activity was discernible even after the N-RNA
complex is purified by CsCl banding, indicating that the
enzyme is tightly bound to the template. To determine
the phosphorylated state of the P protein following phos-
phorylation by the N-RNA-associated kinase (designated
NAK), we incubated P0 with purified N-RNA template in
the presence of [g-32P]ATP. The phosphorylated P was
then analyzed by urea– SDS–PAGE. As shown in Fig.
6A, P0 was converted to P2 form with an electrophoretic
mobility similar to NS2 form produced by virion purified FIG. 7. Phosphorylation of P protein by NAK after treatment with cell
extract. (A) 100 mg of L/P obtained from purified virions were incubatedL/P fraction. Some P1 form (approximately 30% of P2)
with 60 mg of BHK cell extracts in kinase buffer without ATP for 1 hr atwas also discernible, indicating that NAK preparation still
307, immunoprecipitated with 2 ml of anti-PIND antibody. The precipitatescontained low levels of CKII activity. In fact, the level of
were further phosphorylated by 30 mg of N-RNA template in the pres-
CKII activity in different NAK preparations varied consid- ence of [g-32P]ATP and electrophoresed on a 10% urea-SDS gel (lane
erably (data not shown); in some preparation of NAK, the 2) together with the same amount of viral L/P that was directly phos-
phorylated by the same amount of N-RNA template (lane 1). (B) Endolys-CKII activity was totally absent (see below, Fig. 10). These
C digestion of NS2 from A. The migration positions of BRL low molecu-results also suggested that P0 can be directly converted
lar weight markers (kDa) are shown.to P2 without forming P1 intermediate (Barik and Ban-
erjee, 1992a). To further characterize the P2 and NS2
forms, P2 (produced by NAK) and NS2 (produced by L/ CKII activity, as shown by the low level of 32P incorpora-
tion in 75-mer phosphopeptide. In contrast, the level ofP) were subjected to digestion with lysC and the products
analyzed by 20% SDS–PAGE. As shown in Fig. 6B, both 32P incorporation in 32-mer in NS2 form obtained from
both L/P and 32P-labeled virus (Fig. 6B) is consistentlyP2 and NS2 forms released the characteristic 32-mer
phosphopeptide in addition to the 75-mer, indicating that lower (approximately 50%) than the released 75-mer. As-
suming that two S residues in both domains I and II (seethe phosphorylation in NS2 occurred both within 212 to
244 a.a. and within 55 to 76 a.a., i.e., domain II and below) are fully phosphorylated, one would expect to
obtain maximally equal amount of 32P incorporation indomain I, respectively. The presence of the 75-mer phos-
phopeptide in P2 and NS2 indicated that both NAK and both 75- and 32-mer. Thus, a consistent lower 32P incor-
poration in 32-mer is indicative that (a) all sites in domainL/P preparations contained variable levels of CKII. Addi-
tionally, we also digested the NS2 obtained from 32P- II are not labeled with 32P, and (b) some sites in domain
II are already phosphorylated with unlabeled phosphatelabeled virion (Fig. 3) with lysC. As shown in Fig. 6B, it
also released 32-mer and 75-mer phosphopeptides. In group such that additional phosphorylation by LAK re-
sults in disproportionate levels of 32P incorporation. Tocontrast, the P1 species (Fig. 6A) eluted from gel yielded
only the 75-mer. These results suggest that (i) LAK and address these issues, L/P preparation was made from
purified virions and an aliquot was incubated with BHKNAK are similar, if not identical; (ii) P2 and NS2 are identi-
cal and formed after phosphorylation within domain II of cell extract, which preferentially removes phosphate moi-
eties from domain II (Masters and Banerjee, 1986; andthe protein, and (iii) P0 can be converted directly to P2
by NAK (see Discussion below). It is important to mention see below Fig. 8). After incubation, the L/P complex was
precipitated with P antibody and the immunoprecipitatethat the NAK activity can be completely removed from
the N-RNA complex by repeated CsCl gradient (data not was incubated with NAK in the presence of [g-32P]ATP.
NS1 and NS2 species were then separated by PAGE.shown), indicating that NAK, like LAK, is also of cellular
origin. As shown in Fig. 7A, after dephosphorylation, the NS2
species were predominantly phosphorylated by NAKIt was quite apparent in Fig. 6B that the P2 obtained
by phosphorylating P0 by NAK, when digested with lysC, (lane 2) compared to NS1 (compared lane 1 and 2). Fur-
thermore, lysC digestion of the NS2 species from lane 2the level of 32P incorporation in 32-mer is considerably
higher (approximately threefold) than the 75-mer phos- released virtually only the 32P-labeled 32-mer (Fig. 7B,
lane 2), whereas the control NS2 (not treated with BHKphopeptide. These results indicate that the NAK activity
present in the N-RNA template contains trace level of cell extract; Fig. 7A, lane 1) released 75-mer containing
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FIG. 8. Interconversion between P1 and P2. P0 (3 mg) was phosphorylated in vitro with NAK and CKII in the presence of [g-32P]ATP to obtain
P1 and P2 as detailed under Materials and Methods. (A) P1/P2 mixture (100 ng) was then incubated with different amounts of BHK cell extracts
for 1 hr at 307 followed by electrophoresis on 10% urea–SDS–gel. (B) P1 and P2 eluted from the gel were incubated separately with BHK cell
extracts as described in A. (C) Eluted P1 was incubated with N-RNA template for 2 hr at 307 in the presence of 0.1 mM of ATP. The numbers above
the lanes indicate the amount of total protein used (A and B for BHK extract, whereas C for N-RNA complex).
greater amount of 32P than the 32-mer as found pre- hand, was converted into P1 form with approximately
50% loss of radioactivity. These results directly demon-viously in Fig. 6. These results support the contention
that indeed the sites in domain II of NS2 are prephos- strate that P1 is made from P2 by the loss of the phos-
phate groups from domain II. When the 32P-P1 formphorylated accounting for the disproportionate incorpo-
ration of 32P in this domain by LAK/NAK (Fig. 6). eluted from the gel was incubated in the presence of
unlabeled ATP and varying concentrations of NAK, the
P2 form began to appear at higher concentrations of NAKInterconversion between P1 and P2 form
(Fig. 8C). These results indicate that P1 form is converted
Earlier work of Clinton et al. (1979) demonstrated that to P2 by additional phosphorylation in domain II.
NS1 (P1) form is converted into NS2 (P2) both in vitro
and in vivo, strongly suggesting a precursor–product re- LAK/NAK-mediated phosphorylation sites in P protein
lationship between the two species. With the availability
of two protein kinases involved in the phosphorylation of Since NAK can be obtained in relatively large amounts,
subsequent mapping experiments were performed withP protein, namely CKII and LAK/NAK, and exploiting the
high phophatase sensitivity of the phosphate groups in NAK as the source of domain II phosphorylating kinase.
We carried out extensive site-directed mutagenesis indomain II, we reexamined the earlier observation of Clin-
ton et al. (1979) to explore the genesis of the two phos- domain II within 212–242 a.a. as detailed in Fig. 9. The
seven potential phosphorylation sites were altered to ala-phorylated P forms. The P1 and P2 forms were first made
by incubating P0 with NAK and CKII in the presence of nine in various combinations, and the mutant P proteins,
purified from E. coli, were used as substrates for NAK.[g-32P]ATP. After removing [g-32P]ATP from the reaction
mixture, it was incubated in the presence of varying As shown in Fig. 10, only when the S226 and S227 were
altered to alanine (P226/227), no phosphorylation wasamounts of BHK cell extract. As shown in Fig. 8A, the P2
form was selectively dephosphorylated by the phospha- detected. All other single or double mutants were phos-
phorylated efficiently by NAK and phosphorylation oc-tase(s) present in the BHK cell extract as observed pre-
viously (Masters and Banerjee, 1986) confirming the high curred only within domain II as determined by the release
of the 32-mer upon lysC digestion (data not shown).sensitivity of the phosphate groups of P2 to cellular phos-
phatases. To demonstrate interconversion between P1 These results indicate that both S226 and S227 residues
are involved in NAK-mediated phosphorylation. Interest-and P2 form, the respective proteins were eluted from
the gel and incubated individually with BHK cell extract. ingly, for the single mutant P226 or P227, considerable
phosphorylation, 137 and 76%, respectively, was ob-As shown in Fig. 8B, the P1 form was completely resistant
to the phosphatase action. The P2 form, on the other served, suggesting that these two residues may regulate
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DISCUSSION
The phosphoprotein of VSV was designated as NS
protein for over two decades. The existence of two dis-
tinct phosphorylated forms, NS1 and NS2 of Indiana sero-
type, separable by urea–SDS–PAGE, was first demon-
strated by Clinton et al. (1979). The NS1 form and the
more phosphorylated NS2 form were interconvertible by
phosphorylation and dephosphorylation reaction, and the
predominant phosphoamino acid was identified as phos-
phoserine. The precise functions of these two phosphor-
ylated forms, NS1 and NS2, as well as the sites of phos-
phorylation were not clearly understood. Recently, with
the availability of the cDNA clone of the phosphoprotein
gene and its high level expression in unphosphorylated
form in E. coli, there has been a considerable advance-
ment in understanding the phosphorylated states of the
now designated P protein and the role of phosphorylation
in P protein function of the New Jersey serotype of VSV
(PNJ) (Barik and Banerjee, 1991; Barik and Banerjee,
1992a). We have shown that the ubiquitous cellular pro-
tein kinase, CKII, exclusively phosphorylates the S59 and
S61 residues and activates the P protein. This phosphor-
ylated form, designated P1, was subsequently phosphor-
FIG. 9. Schematic representation of VSV(IND) P protein. (A) The entire ylated by L protein-associated kinase (LAK), which con-
P protein containing all domains is shown. The solid dots in domains verted P1 into P2 form separable by DEAE-cellulose chro-
I and II indicate the possible phosphorylation sites. An enlargement of
matography (Barik and Banerjee, 1992a). Moreover,domain II shows the location of seven serine and threonine residues,
conversion of P0 to P2 occurred sequentially in the order,which are potential phosphorylation sites. (B) The different mutant P
proteins are shown with the serine or threonine altered to alanine. P0 r P1 r P2 (Barik and Banerjee, 1992a). Since the
previously designated NS1 and NS2 forms are not easily
discernible in PNJ , the precise relationship between P1
and P2 of PNJ with its corresponding NS1 and NS2 forms,phosphorylation within domain II. It is important to note
if any, remained unclear. Thus, it was important to studythat the NAK activity in N-RNA complex preparation was
the synthesis of P1 and P2 forms of PIND and comparevirtually devoid of CKII activity since no P1 form was
them with the so-called NS1 and NS2 forms which wereobtained, indicating again that NAK can convert P0 di-
rectly into the P2 form. studied extensively in the past.
FIG. 10. Phosphorylation analyses of domain II mutant P proteins using NAK. In vitro phosphorylation of domain II mutant P proteins was carried
out in the presence of N-RNA template as detailed under Material and Methods. The reaction products were analyzed in 10% urea–SDS–
polyacrylamide gel. 32P/protein ratios in the mutants from each experiment were expressed as a percentage of the wild-type 32P/protein ratio from
the same experiment, and the percentage phosphorylation of each mutant was then calculated. The percentage phosphorylation of the wild-type
P protein was taken as 100%. 32P incorporation was measured by phosphoimager, while the amount of protein was detected by Coomassie staining
of the identical SDS–gel (Laemmli, 1970).
AID VY 8401 / 6a28$$$741 02-04-97 20:18:29 vira AP: Virology
210 CHEN, DAS, AND BANERJEE
In this communication, using E. coli-expressed PIND used either from
32P-labeled virion or from in vitro phos-
phorylation reaction using L/P fraction or RNP (Fig. 3).and by site-directed mutagenesis, we have demon-
strated that the P1 form is produced by specific phos- Thus, it seems that CKII-mediated phosphorylation of P
protein produces the P1/NS1 form which is exclusivelyphorylation at S60 and S64 when BHK cell extract was
used as the source of CKII or when P cDNA was ex- phosphorylated within domain I, presumably at S60 and
S64. A similar mapping approach was also described inpressed in COS cells (Figs. 2B and 2C). However, when
recombinant CKII was used to phosphorylate P0 in vitro, an unpublished report by Chang et al. (1994a).
In order to establish the relationship between P2 andT62 was phosphorylated in addition to S60 and S64 (Fig.
2A). The addition of recombinant CKII to BHK cell extract NS2, it was important to obtain the P2 form in vitro. We
made use of our previous observation that both purifieddid not phosphorylate T62 (data not shown) strongly, sug-
gesting that either T62 is not phosphorylated in vivo or L containing LAK activity (Barik and Banerjee, 1992a) and
purified N-RNA complex containing NAK (Masters andthe phosphate group in T62 is highly sensitive to cellular
phosphatases. In fact, using BHK cell extract as the Banerjee, 1986) produced the NS2 form when P(NS) was
incubated with these kinase preparations. We demon-source of CKII we found that approximately 2 mol of
phosphate groups are incorporated per mole of P0 , indi- strate here that the latter activity converted P0 in vitro
into P2 form which migrated with the NS2 form (Fig. 6).cating that two sites are phosphorylated within domain
I (data not shown). Thus, the role of T62 phosphorylation, Subsequently, a similar peptide mapping technique was
used to locate the phoshporylation sites within P2 andseen only with recombinant CK II in vitro, remains un-
clear. Recently, Jackson et al. (1995), expressing similar compared with NS2 form obtained from L/P fraction (Fig.
6) as well as 32P-labeled virion (Fig. 3). The results clearlymutants of PIND in BHK cells using vaccinia virus expres-
sion vector, demonstrated that T62 residue is phosphory- establish that in both P2 and NS2 form, phosphorylation
occurred within 212 to 242 a.a. (32-mer) located withinlated in addition to S60 and S64 in vivo. However, muta-
tion of the latter two residues resulted in no phosphoryla- domain II (Fig. 6). By extensive mutational analysis we
further mapped precisely the phosphorylation sitestion of T62. Interestingly, single mutation in S64 yielded
no phosphothreonine. These findings led Jackson et al. within domain II using NAK as the source of domain II
phosphorylating kinase. Two serine residues, S226 and(1995) to speculate on a possible involvement of a sepa-
rate cellular kinase in phosphorylating T62 residue. How- S227, seemed to be involved in phosphorylation of do-
main II (Fig. 10). Interestingly, single mutant P226 or P227ever, our finding that mutation of T62 has little effect (11%;
Fig 2C) on the overall phosphorylation of the P protein resulted in wild-type level of phosphorylation, suggesting
that other S residues within 212 to 242 a.a. may be ex-suggests that T62 phosphorylation, if any, may not have
any role in P function. Interestingly, Gao and Lenard posed for subsequent phosphorylation. On the other
hand, the double mutant P226/227 is totally defective in(1995b), using E. coli-expressed P0 protein, failed to de-
tect phosphorylation of S64 residue in vitro by recombi- phosphorylation, suggesting that these two ser residues
are phosphorylated within domain II. Alternatively, thesenant CKII, using S60/T62 double mutant. The reasons for
this apparent discrepancy between their results and ours residues may not be the phosphate acceptors rather al-
tering these amino acids to alanine has an unknownare not clear at this moment. From mutational studies, it
appears that T49 and S52 are not involved in phosphory- structural effect on the protein that leads to no phosphor-
ylation within domain II. Amino acid sequence analysislation either in vitro or in vivo. However, we cannot rule
out the possibility that these residues are phosphorylated within domain II of 32P-labeled P2 protein would help us
to identify the precise phosphoserine residues involvedby a cellular kinase other than CKII, the phosphate
groups of these residues may rapidly turn over or be in NAK-mediated phosphorylation. Recently, Gao and
Lenard (1995b) have shown that S227 and S233 whensensitive to phosphatase(s) in the infected cells.
Having established the phosphorylated sites in CKII- altered to alanine resulted in phosphorylation negative
P protein by LAK. The reasons for this apparent discrep-mediated phosphorylation, we then developed a peptide
map analysis to isolate a peptide fragment that would ancy is not clear at this moment.
With the availability of purified P1/NS1 and P2/NS2, itspan the phosphorylation sites within the P1 protein. This
was achieved by proteolytic cleavage of P1 protein with was possible to directly address the question of intercon-
version between the two phosphorylated P species (Clin-lysC followed by chymotrypsin that would yield a 21-mer
phosphopeptide containing the domain I phosphorylation ton et al., 1979). It was quite apparent from our studies
that P2/NS2 form can be converted into P1/NS1 formsites, i.e., 55 to 76 (Fig. 4). In addition, lysC treatment
would also produce a peptide fragment of 32-mer, repre- following dephosphorylation of phosphate moieties from
domain II by cellular phosphatases (Fig. 8). Moreover,senting the presumptive phosphorylation region within
domain II, i.e., 212–242 a.a. Using this method we con- incubation of P1/NS1 with NAK resulted in the appear-
ance of P2/NS2 form, indicating P2/NS2 can be formedfirmed the sites of phosphorylation in P1 protein to be
within 55 to 76 a.a. (21-mer). A similar 21-mer phospho- by additional phosphorylation within domain II. It is im-
portant to note that P0 form can be directly converted intopeptide was also released when the NS1 protein was
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in vitro adenylation of RNA by vesicular stomatitis virus. Virology 61,P2 form by phosphorylation with NAK (Fig. 10). Moreover,
547–558.domain I mutant (defective in CKII-mediated phosphory-
Barik, S., and Banerjee, A. K. (1991). Cloning and expression of the
lation) was also converted into P2 following phosphoryla- vesicular stomatitis virus phosphoprotein gene in Escherichia coli:
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kinase II is essential for transcriptional activity of vesicular stomatitistheir mode of phosphorylation. Further structure/function
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International Conference on Negative strand Viruses, Estoril, Portu-P protein of VSV, cellular CKII and a yet unidentified
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Chang, T. L., Reiss, C. S., and Huang, A. S. (1994b). Inhibition of vesicu-
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ization of this protein kinase would help us understand J. Virol. 68, 4980–4987.
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